| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/16/2004 | EP1427730A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004011005A3 Antimicrobial 2, 4-diamino-pteridine derivatives |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 05/27/2004 | WO2004043338A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | CA2492103A1 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/21/2004 | WO2004042002A2 Compounds for modulating rna interference |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040096787 Color photography |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | US20040082784 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease |
| 04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
| 04/22/2004 | US20040077859 Immunosuppressive effects of pteridine derivatives |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/20/2004 | US6723346 Flowable, non-dusty, and binder-free riboflavin granulates can be manufactured from a mixture of riboflavin crystals of modification b and c |
| 04/15/2004 | WO2004031189A1 Pyridino and pyrimidino pyrazinones for treatment of anxiety and depression |
| 04/15/2004 | US20040072837 Filtration; freeze drying; anticancer agents |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
| 04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 03/30/2004 | CA2128205C Methotrexate derivatives |
| 03/25/2004 | WO2003051366A3 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/10/2004 | EP1200437B1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 02/26/2004 | WO2003103575A3 Compounds, compositions, and methods |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/19/2004 | US20040034029 Composition and method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone |
| 02/19/2004 | US20040033535 Antibodies to OPGL |
| 02/18/2004 | EP1389209A1 Folate mimetics and folate-receptor binding conjugates thereof |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/12/2004 | WO2004013142A1 A riboflavin derivative and its manufacture and uses |
| 02/12/2004 | US20040029885 New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 02/11/2004 | CN1474651A Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 02/05/2004 | WO2004011005A2 Antimicrobial 2, 4-diamino-pteridine derivatives |
| 02/05/2004 | US20040023913 Agent with inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1472235A Folic acid-polydiol compound and its medicinal composition |
| 01/29/2004 | WO2004009036A2 Compounds compositions and methods |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469867A Novel phenylalanine derivatives |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/14/2004 | EP1380298A2 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/13/2004 | US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/08/2004 | US20040006028 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373225A1 Process for coupling amino acids to an antifolate scaffold |
| 12/30/2003 | US6670349 Asthma |
| 12/30/2003 | US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone |
| 12/25/2003 | US20030236255 Immunosuppressive effects of pteridine derivatives |
| 12/18/2003 | WO2003103575A2 Compounds, compositions, and methods |
| 12/18/2003 | US20030232835 Nitrogen compounds such as tetrahydrobiopterin, used as hypotensive agents and prevention or urogenital disorders due nitric oxide synthase (NOS) |
| 12/11/2003 | US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents |
| 12/10/2003 | EP1368308A1 Cannabinoid receptor ligands |
| 12/10/2003 | EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |